5 days Amicus Therapeutics (NASDAQ:FOLD) PT Lowered to $18.00 at Morgan StanleyMarketBeat
Morgan Stanley cut their target price on shares of Amicus Therapeutics from $19.00 to $18.00 and set an “overweight” rating for the company in a report on Friday.
Morgan Stanley (MS) · Nasdaq 100
X